@article{article, title  = {{CHAMPAIN study: Initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency}},

 publisher = {{Bioscientifica}},

 url = {{http://dx.doi.org/10.1530/endoabs.99.rc3.4 }},

 year = {{2024}},

 month = {{5}},

 author = {{Prete A and Theiler-Schwetz V and Arlt W and Chifu I-O and Harbeck B and Napier C and Newell-Price JDC and Rees A and Reisch N and Stalla GK and Aslam N et al}},

 doi = {{10.1530/endoabs.99.rc3.4}},

 journal = {{Endocrine Abstracts}},

 note = {{Accessed on 2024/12/22}}}